Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

CIO vs CHCT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CHCT Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 7–3 Matrix Metrics)

CHCT Overall Winner 6-Pillar Tally: CIO 0 – 5 CHCT (1 Tie) Matrix Metrics: CIO 3 – 7 CHCT

As of Nov 17, 2026, Community Healthcare Trust Incorporated (CHCT) is the stronger overall head-to-head candidate over City Office Reit, Inc. (CIO) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CIO carries a Unified Composite Score of 66.2/100 (BUY) at $6.99 (N/M Forward P/E, 19.6% operating margin), whereas CHCT carries 28.1/100 (SELL) at $14.52 (37.3x Forward P/E, 28.1% operating margin).

  • Composite vs. Pillar Nuance: While CIO currently prints a higher short-term Unified Composite Score (66.2/100 BUY vs. CHCT 28.1/100 SELL), CHCT captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (28.1% vs. 19.6% operating margin) and revenue trajectory (+4.4% vs. -12.0% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CIO vs CHCT
CIO NYSE
City Office Reit, Inc.
Real Estate Investment Trusts
$6.99
-0.14% 1D
Market Cap $282.5M
TTM Revenue $164M
Forward P/E N/M
Beta / 30D Vol 0.19β · 2% Vol
Unified Composite Score
66.2 / 100 BUY
Tech 75.0 Fund 65.0 Flow 50.0 Mom 70.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 65
RSI-14: 64.9 · SMA20: $6.97 · SMA50: $6.92
CHCT NYSE Head-to-Head Winner
Community Healthcare Trust Incorporated Common Stock, $0.01 par value per share
Real Estate Investment Trusts
$14.52
-1.49% 1D
Market Cap $422.8M
TTM Revenue $126M
Forward P/E 37.3x
Beta / 30D Vol 0.19β · 45% Vol
Unified Composite Score
28.1 / 100 SELL
Tech 8.0 Fund 34.0 Flow 50.0 Mom 54.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 58
RSI-14: 58.4 · SMA20: $13.86 · SMA50: $13.93

6-Pillar Scorecard Institutional Category Breakdown (CIO 0 – 5 CHCT)

Columns: Metric · CIO · CHCT
1. Valuation Multiples CHCT
Forward P/E N/M 37.3x
Trailing P/E N/M 20.1x
PEG Ratio N/M N/M
EV / Revenue 1.7x 3.4x
2. Growth & Scale CHCT
Revenue Growth (YoY) -12.0% +4.4%
Earnings Growth (YoY) -52.3% +179.9%
TTM Revenue (USD) $164M $126M
Market Cap $282.5M $422.8M
3. Profitability & Quality CHCT
Gross Margin 60.5% 80.8%
Operating Margin 19.6% 28.1%
Net Profit Margin -74.2% 17.8%
Return on Equity (ROE) -17.8% 5.3%
4. Balance Sheet & Cash Flow CHCT
Cash Generation (TTM) $83M EBITDA $80M EBITDA
Cash Flow Margin 51.0% EBITDA Mgn 63.2% EBITDA Mgn
Net Cash / Leverage $12.34 Book/Sh · -17.8% ROE $15.26 Book/Sh · 5.3% ROE
Dividend Yield 4.29% 11.24%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 38.6% (35th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat CHCT
OpEx & R&D Intensity 40.9% of Rev ($67M) 52.7% of Rev ($66M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role REIT - Office Operator REIT - Healthcare Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CIO (3) vs CHCT (7)
Institutional Metric CIO CHCT Criterion Row Edge
Market Capitalization
Scale
$282.5M $422.8M Larger Scale CHCT
Trailing P/E Ratio
Valuation
N/M 20.1x Lower Multiple CHCT
Forward P/E Ratio
Valuation
N/M 37.3x Lower Multiple CHCT
Revenue Growth (YoY)
Growth
-12.0% +4.4% Higher Growth CHCT
Operating Margin (TTM)
Profitability
19.6% 28.1% Higher Margin CHCT
Net Profit Margin
Profitability
-74.2% 17.8% Higher Margin CHCT
Return on Equity (ROE)
Capital Efficiency
-17.8% 5.3% Higher ROE CHCT
52-Week Range Position
Momentum
99% ($4–$7) 30% ($13–$19) Stronger Trend CIO
Beta / 30D Volatility
Risk Regime
0.19β · 2% Vol 0.19β · 45% Vol Lower Realized Risk CIO
Unified Institutional Score
Composite Signal
66.2 / 100 (BUY) 28.1 / 100 (SELL) Higher Composite CIO
Trailing 12M Revenue (USD)
Operating Scale
$164M $126M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
60.5% 80.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.7x EV/Rev N/M PEG · 3.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$83M EBITDA ($12.34 Book/Sh · -17.8% ROE) $80M EBITDA ($15.26 Book/Sh · 5.3% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CHCT +9.88 pp
CIO: +0.58% · CHCT: +10.46%
3M Horizon CHCT +12.15 pp
CIO: +1.3% · CHCT: +13.45%
6M Horizon CHCT +12.15 pp
CIO: +1.3% · CHCT: +13.45%
1Y Horizon CHCT +12.15 pp
CIO: +1.3% · CHCT: +13.45%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CIO vs CHCT. Trailing 12-month operating profitability (CIO 19.6% vs CHCT 28.1%) and valuation multiples (CIO N/M vs CHCT 37.3x Forward P/E) are benchmarked directly in Pillar 4 below.

CIO ADR TTM Benchmark FX-Normalized USD
TTM Revenue$164M
Gross Margin60.5%
Op. Margin19.6%
ROE / Fwd P/E-17.8% · N/M
CHCT ADR TTM Benchmark FX-Normalized USD
TTM Revenue$126M
Gross Margin80.8%
Op. Margin28.1%
ROE / Fwd P/E5.3% · 37.3x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CIO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CIO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CHCT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 38.6%
IV Percentile 35th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CHCT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CIO Moat Profile Scale & Operating Efficiency Moat
REIT - Office Operator
Competes within the REIT - Office value chain with $282.5M market capitalization and 19.6% operating margin.
OpEx & R&D Reinvestment 40.9% of Rev ($67M)
90D Engineering Disclosures 0 Published
CHCT Moat Profile Scale & Operating Efficiency Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $422.8M market capitalization and 28.1% operating margin.
OpEx & R&D Reinvestment 52.7% of Rev ($66M)
90D Engineering Disclosures 0 Published

Investor FAQ CIO vs CHCT Key Questions & Quantitative Answers

As of Nov 17, 2026, Community Healthcare Trust Incorporated (CHCT) is the stronger overall head-to-head candidate over City Office Reit, Inc. (CIO) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CIO carries a Unified Composite Score of 66.2/100 (BUY) at $6.99 (N/M Forward P/E, 19.6% operating margin), whereas CHCT carries 28.1/100 (SELL) at $14.52 (37.3x Forward P/E, 28.1% operating margin). Composite vs. Pillar Nuance: While CIO currently prints a higher short-term Unified Composite Score (66.2/100 BUY vs. CHCT 28.1/100 SELL), CHCT captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (28.1% vs. 19.6% operating margin) and revenue trajectory (+4.4% vs. -12.0% YoY).

CHCT leads the Growth & Scale pillar: CIO posts -12.0% YoY revenue growth and -52.3% YoY earnings growth on $164M TTM revenue (60.5% gross margin, 19.6% operating margin), compared with CHCT at +4.4% YoY revenue growth and +179.9% YoY earnings growth on $126M TTM revenue (80.8% gross margin, 28.1% operating margin). On trailing 12-month operating scale, CIO generates $164M in USD-normalized revenue versus $126M for CHCT. In operating R&D and SG&A reinvestment, CIO deploys 40.9% of Rev ($67M) (0 90-day corporate R&D disclosures) versus 52.7% of Rev ($66M) (0 disclosures) for CHCT.

CHCT screens cheaper on headline valuation multiples. CIO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.7x EV/Revenue (51.0% EBITDA margin), whereas CHCT trades at 37.3x Forward P/E, 20.1x Trailing P/E, N/M PEG, and 3.4x EV/Revenue (63.2% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CIO (-17.8% ROE) versus CHCT (5.3% ROE) capital efficiency.

In options market volatility and institutional positioning, CIO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.19β · 2% Vol realized risk). By comparison, CHCT carries 38.6% implied volatility (35th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.19β · 45% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.